Recruiting
DNA Analysis of Blood and Tissue From Patients With Lung Cancer
About this study
RATIONALE: Studying samples of blood and tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help the study of cancer in the future. PURPOSE: This clinical trial is analyzing the DNA in blood and tissue samples from patients with lung cancer.
- Condition
- Lung Cancer
- Sponsor
- Massachusetts General Hospital
Who can join
- Age
- 18 to 120 years
- Sex
- All sexes
- Healthy volunteers
- Accepted
Inclusion 12
- Minimum age: 18 years
- Maximum age: 120 years
- Study condition: Lung Cancer
- DISEASE CHARACTERISTICS:
- Patient:
- Newly diagnosed primary lung cancer
- Patient at Massachusetts General Hospital (MGH) or Boston Medical Center Cancer Center
- PATIENT CHARACTERISTICS:
- Not specified
- PRIOR CONCURRENT THERAPY:
- EXCLUSIONS:
- Vulnerable populations are excluded. Patients with metastasis from another site to lung or mesothelioma are excluded.
Where
2 sites, 2 recruiting
Massachusetts General Hospital
Boston, Massachusetts, United States
Harvard School of Public Health
Boston, Massachusetts, United States
Potential match only. Final eligibility is determined by the study team.